1,1-Difluoroethane Hydrocarbon Cardiomyopathy.
Autor: | Brown KN; Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Gronbeck K; Department of Emergency Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Azmeen A; Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Siddique A; Division of Cardiothoracic Surgery, University of Nebraska Medical Center, Omaha, Nebraska., Zolty R; Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Sullivan JN; Department of Anesthesiology, University of Nebraska Medical Center, Omaha, Nebraska. |
---|---|
Jazyk: | angličtina |
Zdroj: | JACC. Case reports [JACC Case Rep] 2022 Dec 23; Vol. 7, pp. 101716. Date of Electronic Publication: 2022 Dec 23 (Print Publication: 2023). |
DOI: | 10.1016/j.jaccas.2022.101716 |
Abstrakt: | 1,1-Difluoroethane (DFE) cardiomyopathy results from the direct inhalation of toxic halogenated hydrocarbons. We present a case series of acute DFE cardiomyopathy illustrating the typical presentation of severe DFE cardiomyopathy along with a detailed description of its mechanism of injury. ( Level of Difficulty: Advanced. ). Competing Interests: The authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2023 The Authors.) |
Databáze: | MEDLINE |
Externí odkaz: |
načítá se...